Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announces its Vela(TM) platform has received the US Food and Drug Administration (FDA) 510(k) pre-marketing clearance and CE Mark certification in the European Union for the temporary reduction of thigh circumference. This announcement marks the first FDA clearance and CE Mark certification
n for a product designed to reduce circumferences in the body.
The Syneron Vela platform previously received clearance by the FDA for cellulite treatment. This new clearance enhances Syneron's leading position in the fast-growing global market of non-invasive body shaping and contouring.
Hat Tip: Medgadget
Great blog! Thanks. I recently had cellulite treatment done and by accident I stumbled upon www.thepatientsadvantage.com. I used them when looking for a provider.
ReplyDeleteWhat I liked the most was that my profile remained anynomyous until I was ready to decide what to do. I received replies from four surgeons that met all the things I was looking for. I liked having that complete control without the sales pressure that some of these places can be known for.
If you are going to go down the cosmetic surgery road...better to be safe than sorry. Check them out.
Thank you for posting the information on your success and the search for the appropriate surgeon.
ReplyDelete